Fibroblast Growth Factor-2 Is Required for Vasa Vasorum Plexus Stability in Hypercholesterolemic Mice
Author(s) -
Jessica Mollmark,
Andrew J.-H. Park,
Justin Kim,
Thomas Z. Wang,
Sarah Katzenell,
Samantha Shipman,
Lyubomir Zagorchev,
Michael Simons,
Mary Jo MulliganKehoe
Publication year - 2012
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.112.252544
Subject(s) - vasa vasorum , fibroblast growth factor , plasmin , adventitia , endocrinology , plasminogen activator , medicine , receptor , chemistry , biology , microbiology and biotechnology , anatomy , biochemistry , enzyme
Vasa vasorum are angiogenic in advanced stages of human atherosclerosis and hypercholesterolemic mouse models. Fibroblast growth factor-2 (FGF-2) is the predominant angiogenic growth factor in the adventitia and plaque of hypercholesterolemic low-density lipoprotein receptor-deficient/apolipoprotein B(100/100) mice (DKO). FGF-2 seems to play a role in the formation of a distinct vasa vasorum network. This study examined the vasa vasorum structure and its relationship to FGF-2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom